Compare TTK HEALTHCARE with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE JUBILANT LIFE SCIENCES TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 22.1 16.2 136.6% View Chart
P/BV x 1.5 1.8 82.0% View Chart
Dividend Yield % 1.0 0.8 126.5%  

Financials

 TTK HEALTHCARE   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
JUBILANT LIFE SCIENCES
Mar-19
TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,215898 135.3%   
Low Rs610618 98.8%   
Sales per share (Unadj.) Rs444.4572.0 77.7%  
Earnings per share (Unadj.) Rs17.236.2 47.6%  
Cash flow per share (Unadj.) Rs27.659.5 46.4%  
Dividends per share (Unadj.) Rs5.004.50 111.1%  
Dividend yield (eoy) %0.50.6 92.3%  
Book value per share (Unadj.) Rs177.9301.9 58.9%  
Shares outstanding (eoy) m14.13159.28 8.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.11.3 155.0%   
Avg P/E ratio x52.920.9 253.0%  
P/CF ratio (eoy) x33.012.7 259.4%  
Price / Book Value ratio x5.12.5 204.3%  
Dividend payout %29.012.4 233.4%   
Avg Mkt Cap Rs m12,894120,694 10.7%   
No. of employees `0002.32.4 96.7%   
Total wages/salary Rs m1,30719,260 6.8%   
Avg. sales/employee Rs Th2,715.738,120.6 7.1%   
Avg. wages/employee Rs Th565.38,058.4 7.0%   
Avg. net profit/employee Rs Th105.42,414.3 4.4%   
INCOME DATA
Net Sales Rs m6,27991,108 6.9%  
Other income Rs m78357 21.7%   
Total revenues Rs m6,35691,466 6.9%   
Gross profit Rs m49617,390 2.8%  
Depreciation Rs m1473,709 4.0%   
Interest Rs m342,198 1.5%   
Profit before tax Rs m39311,840 3.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m1493,268 4.6%   
Profit after tax Rs m2445,770 4.2%  
Gross profit margin %7.919.1 41.4%  
Effective tax rate %37.927.6 137.4%   
Net profit margin %3.96.3 61.3%  
BALANCE SHEET DATA
Current assets Rs m2,71745,848 5.9%   
Current liabilities Rs m1,57120,897 7.5%   
Net working cap to sales %18.327.4 66.7%  
Current ratio x1.72.2 78.8%  
Inventory Days Days3257 56.6%  
Debtors Days Days4751 91.6%  
Net fixed assets Rs m99165,498 1.5%   
Share capital Rs m141159 88.7%   
"Free" reserves Rs m2,37347,930 5.0%   
Net worth Rs m2,51448,089 5.2%   
Long term debt Rs m342,429 0.0%   
Total assets Rs m4,158114,685 3.6%  
Interest coverage x12.66.4 197.5%   
Debt to equity ratio x00.9 0.2%  
Sales to assets ratio x1.50.8 190.1%   
Return on assets %6.76.9 96.1%  
Return on equity %9.712.0 80.8%  
Return on capital %16.912.4 136.4%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22512,422 1.8%   
Fx outflow Rs m7117,227 0.4%   
Net fx Rs m154-4,805 -3.2%   
CASH FLOW
From Operations Rs m17311,215 1.5%  
From Investments Rs m97-10,118 -1.0%  
From Financial Activity Rs m-3076,574 -4.7%  
Net Cashflow Rs m-387,612 -0.5%  

Share Holding

Indian Promoters % 65.4 45.6 143.4%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 3.7 8.7 42.5%  
FIIs % 5.2 21.2 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 21.1 122.3%  
Shareholders   12,723 23,815 53.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Slow Economy? There's Still Good Money to Be Made in the Markets(Podcast)

Indian stock markets mostly remained in the negative zone during the week except for Wednesday.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 20, 2020 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS